Annual ROE
-80.27%
-46.56%-138.12%
December 31, 2023
Summary
- As of February 6, 2025, XTLB annual return on equity is -80.27%, with the most recent change of -46.56% (-138.12%) on December 31, 2023.
- During the last 3 years, XTLB annual ROE has risen by +1.51% (+1.85%).
- XTLB annual ROE is now -100.22% below its all-time high of 36.96 thousand%, reached on December 31, 2009.
Performance
XTLB ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-34.34%
-5.33%-18.37%
September 30, 2024
Summary
- As of February 6, 2025, XTLB quarterly return on equity is -34.34%, with the most recent change of -5.33% (-18.37%) on September 30, 2024.
- Over the past year, XTLB quarterly ROE has dropped by -20.05% (-140.31%).
- XTLB quarterly ROE is now -104.29% below its all-time high of 800.86%, reached on June 30, 2010.
Performance
XTLB Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
XTLB ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -138.1% | -140.3% |
| 3 y3 years | +1.9% | -140.3% |
| 5 y5 years | -260.8% | +2.1% |
XTLB ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -1083.7% | at low | -204.3% | +51.6% |
| 5 y | 5-year | -1083.7% | +1.9% | -204.3% | +51.6% |
| alltime | all time | -100.2% | +93.6% | -104.3% | +93.7% |
XTL Biopharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -34.34%(+18.4%) |
| Jun 2024 | - | -29.01%(+103.0%) |
| Mar 2024 | - | -14.29%(-76.7%) |
| Dec 2023 | -80.27%(+138.1%) | -61.37%(-6.9%) |
| Sep 2023 | - | -65.89%(-7.1%) |
| Jun 2023 | - | -70.93%(+18.9%) |
| Mar 2023 | - | -59.68%(+125.6%) |
| Dec 2022 | -33.71%(-513.1%) | -26.45%(-186.9%) |
| Sep 2022 | - | 30.43%(-7.6%) |
| Jun 2022 | - | 32.92%(+119.9%) |
| Mar 2022 | - | 14.97%(+35.1%) |
| Dec 2021 | 8.16%(-110.0%) | 11.08%(-116.5%) |
| Sep 2021 | - | -67.14%(+11.1%) |
| Jun 2021 | - | -60.42%(+17.5%) |
| Mar 2021 | - | -51.42%(+3.6%) |
| Dec 2020 | -81.78%(+598.4%) | -49.61%(+41.4%) |
| Sep 2020 | - | -35.09%(-2.9%) |
| Jun 2020 | - | -36.13%(-30.1%) |
| Mar 2020 | - | -51.70%(+488.2%) |
| Dec 2019 | -11.71%(-123.5%) | -8.79%(-153.4%) |
| Sep 2019 | - | 16.46%(-62.8%) |
| Jun 2019 | - | 44.19%(-47.8%) |
| Mar 2019 | - | 84.60%(+42.6%) |
| Dec 2018 | 49.91%(-331.3%) | 59.32%(+65.1%) |
| Sep 2018 | - | 35.94%(-37.2%) |
| Jun 2018 | - | 57.27%(+103.5%) |
| Mar 2018 | - | 28.14%(-211.8%) |
| Dec 2017 | -21.58%(-77.2%) | -25.16%(-60.1%) |
| Sep 2017 | - | -63.09%(-47.0%) |
| Jun 2017 | - | -119.14%(+49.5%) |
| Mar 2017 | - | -79.69%(+24.4%) |
| Dec 2016 | -94.72%(+7.4%) | -64.06%(-15.6%) |
| Sep 2016 | - | -75.92%(+10.9%) |
| Jun 2016 | - | -68.46%(+8.3%) |
| Mar 2016 | - | -63.20%(-10.5%) |
| Dec 2015 | -88.21%(+43.5%) | -70.62%(+44.7%) |
| Sep 2015 | - | -48.81%(-7.5%) |
| Jun 2015 | - | -52.79%(-9.0%) |
| Mar 2015 | - | -58.04%(+18.4%) |
| Dec 2014 | -61.48% | -49.03%(-20.7%) |
| Sep 2014 | - | -61.85%(+44.4%) |
| Jun 2014 | - | -42.83%(-5.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | -45.20%(+2.3%) |
| Dec 2013 | -59.27%(+213.6%) | -44.19%(+130.8%) |
| Sep 2013 | - | -19.15%(-31.2%) |
| Jun 2013 | - | -27.85%(+14.0%) |
| Mar 2013 | - | -24.43%(+31.4%) |
| Dec 2012 | -18.90%(-46.1%) | -18.59%(-18.6%) |
| Sep 2012 | - | -22.84%(-27.7%) |
| Jun 2012 | - | -31.60%(+17.3%) |
| Mar 2012 | - | -26.94%(-10.3%) |
| Dec 2011 | -35.05%(-21.0%) | -30.03%(-7.7%) |
| Sep 2011 | - | -32.55%(-24.9%) |
| Jun 2011 | - | -43.34%(-40.7%) |
| Mar 2011 | - | -73.08%(-53.6%) |
| Dec 2010 | -44.35%(-100.1%) | -157.39%(-15.7%) |
| Sep 2010 | - | -186.65%(-123.3%) |
| Jun 2010 | - | 800.86%(+1133.4%) |
| Mar 2010 | - | 64.93%(-3.4%) |
| Dec 2009 | 36.96 K%(-3056.2%) | 67.20%(-163.0%) |
| Sep 2009 | - | -106.73%(-76.7%) |
| Jun 2009 | - | -458.96%(-16.1%) |
| Mar 2009 | - | -546.81%(+252.3%) |
| Dec 2008 | -1250.14%(+685.1%) | -155.23%(+4.9%) |
| Sep 2008 | - | -147.95%(+61.4%) |
| Jun 2008 | - | -91.67%(-52.7%) |
| Mar 2008 | - | -193.99%(+51.1%) |
| Dec 2007 | -159.23%(+79.0%) | -128.41%(-17.6%) |
| Sep 2007 | - | -155.79%(+21.8%) |
| Jun 2007 | - | -127.94%(+78.2%) |
| Mar 2007 | - | -71.78%(-6.6%) |
| Dec 2006 | -88.98%(-2.1%) | -76.88%(-0.1%) |
| Sep 2006 | - | -76.97%(-18.9%) |
| Jun 2006 | - | -94.88%(-17.5%) |
| Mar 2006 | - | -115.04%(+16.0%) |
| Dec 2005 | -90.85%(+10.9%) | -99.19%(+26.7%) |
| Sep 2005 | - | -78.30%(-10.4%) |
| Jun 2005 | - | -87.43%(-16.4%) |
| Mar 2005 | - | -104.57%(-9.4%) |
| Dec 2004 | -81.93%(+18.2%) | -115.46%(-8.5%) |
| Sep 2004 | - | -126.16%(+45.0%) |
| Jun 2004 | - | -87.01% |
| Dec 2003 | -69.33%(+40.9%) | - |
| Dec 2002 | -49.21%(+101.7%) | - |
| Dec 2001 | -24.40% | - |
FAQ
- What is XTL Biopharmaceuticals annual return on equity?
- What is the all time high annual ROE for XTL Biopharmaceuticals?
- What is XTL Biopharmaceuticals annual ROE year-on-year change?
- What is XTL Biopharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for XTL Biopharmaceuticals?
- What is XTL Biopharmaceuticals quarterly ROE year-on-year change?
What is XTL Biopharmaceuticals annual return on equity?
The current annual ROE of XTLB is -80.27%
What is the all time high annual ROE for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high annual return on equity is 36.96 K%
What is XTL Biopharmaceuticals annual ROE year-on-year change?
Over the past year, XTLB annual return on equity has changed by -46.56% (-138.12%)
What is XTL Biopharmaceuticals quarterly return on equity?
The current quarterly ROE of XTLB is -34.34%
What is the all time high quarterly ROE for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high quarterly return on equity is 800.86%
What is XTL Biopharmaceuticals quarterly ROE year-on-year change?
Over the past year, XTLB quarterly return on equity has changed by -20.05% (-140.31%)